Form 4 for PCSA Processa Pharmaceuticals, Inc.
Accepted 2025-04-11 00:00:00 ET · period of report 2025-04-01 · accession 0000897069-25-000791 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-04-11 | 2025-04-01 | PCSA | Guy Wendy | Chief Administrative Off | M - OptEx | — | +14.5K | 26.3K | +122% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-04-01 | M | A | 14,482 | — | 26,339 | D | — | — | (F1) Distribution of vested restricted shares. |